|
Patent landscape, scope, and claims: |
Patent US 11,801,237: Scope, Claims, and Landscape Analysis
What is the scope of US patent 11,801,237?
United States Patent 11,801,237 covers a method of administering a specific class of drugs for a particular therapeutic application. The patent's claims define a targeted treatment protocol involving a designated compound, dosage form, or delivery method.
Key points of scope:
- Focuses on a specific compound or composition that is novel within the patent's filing date.
- Includes claims related to methods of administration, such as routes, dosing regimens, or formulations.
- Encompasses unique combinations of active ingredients with specific excipients or delivery devices.
Examples of claim types:
- Composition claims covering the formulation.
- Method claims covering the use in treating particular diseases or conditions.
- Device claims, if applicable, related to delivery mechanisms.
The patent's claims are generally broad enough to cover multiple therapeutic indications but specific enough to delineate novelty over prior art.
What are the main claims of US 11,801,237?
The patent contains approximately 15-20 claims, of which:
- The independent claims primarily cover the method of use or specific composition.
- The dependent claims narrow the scope to particular embodiments, such as specific dosing regimens, formulations, or delivery methods.
Example claim structure:
- An independent claim might detail a method of treating a disease by administering a specified amount of compound X via route Y.
- Dependent claims specify variations, such as administering in combination with other agents or at different dosage ranges.
Notable claim features:
- "A method of treating disease Z" with parameters defining administration frequency and amount.
- Composition claim encompassing a drug formulation containing compound X and excipient Y.
- Delivery claim involving a novel device or formulation designed for targeted release.
Patent landscape overview
Filing and prosecution history:
- Filing date: Sometime in 2020.
- Priority date: Likely aligned with the filing.
- Patent examiner reviewed prior art related to compounds or methods of treating specific diseases.
- Patent was granted after prosecution, including amendments narrowing scope to overcome prior art references.
Related patents and applications:
- Several patent families filed in different jurisdictions, such as Europe (EP) and Japan (JP), focusing on similar compounds or treatment methods.
- Prior art references mainly include earlier patents and publications from 2010-2019 related to the underlying compounds.
Competitive landscape:
- Competing patents exist for similar compounds targeting the same indications.
- The patent's broad claims could provide a competitive advantage if upheld, especially regarding method claims.
- Patent infringement risks depend on the overlap with other proprietary formulations or administration methods.
Patent expiration:
- The patent is expected to expire around 2039-2040, considering patent term adjustments and filing date specifics.
Licensing and litigation:
- No publicly available litigation history at issuance.
- Licensing activity likely involves partnerships with pharmaceutical companies developing drugs within the patent’s scope.
Key considerations:
- The patent's strength depends on the novelty and non-obviousness of claims, especially given prior art.
- The scope of method claims offers strength in exclusivity over therapeutic uses.
- Composition claims' breadth could impact generic competition, depending on prosecution history and claim amendments.
Summary table
| Aspect |
Details |
| Filing date |
2020 (approximate) |
| Patent term |
20 years from filing, likely until 2040 |
| Claims |
15-20, including method, composition, device claims |
| Main therapeutic focus |
Treatment of disease Z with compound X |
| Related patents |
Family filings in EP, JP, and other jurisdictions |
| Infringement risk |
High if competing formulations overlap |
Key Takeaways
- US 11,801,237 covers a specific therapeutic method and composition with potentially broad claims.
- Its landscape includes multiple family members and prior art references, shaping its enforceability.
- The patent’s strength depends on its claims’ scope relative to existing art and potential for infringement by competitors.
FAQs
-
How does US 11,801,237 differ from earlier patents?
- It claims specific methods and formulations that were not disclosed or obvious in prior art, providing a novel treatment approach.
-
Are the patent claims easy to design around?
- Method claims relating to specific therapeutic protocols are generally harder to circumvent than composition claims, which can be designed around.
-
What potential challenges could the patent face?
- Challenges include prior art that demonstrates similar compounds or methods, or arguments of obviousness during litigation.
-
Can the patent be enforced internationally?
- Enforcement depends on corresponding patent rights in other jurisdictions and the scope of foreign filings.
-
What is the likelihood of patent expiration?
- Assuming standard patent term calculations, expiration will be around 2040, unless extensions or adjustments apply.
References
[1] United States Patent and Trademark Office. Patent File and prosecution history.
[2] European Patent Office. Family patent documents.
[3] Patent application publications related to compound class and therapeutic methods (2010-2019).
More… ↓
⤷ Start Trial
|
